Stem Cell Clinic

Phoenix Pain Management Doctors at Arizona Pain Stem Cell Institute Now Offering 4 Stem Cell Treatments for Arthritis

By Stem Cell Treatment

Phoenix, Arizona (PRWEB) December 11, 2013

The top Phoenix stem cell treatment clinic, Arizona Pain Stem Cell Institute, is now offering four stem cell therapies for arthritis. The treatments offered are very low risk and offered as an outpatient. For more information and scheduling on the regenerative medicine treatments offered, call (602) 507-6550.

The Board Certified, Award Winning pain management doctors in Arizona provide either bone marrow, fat derived or amniotic stem cell injections. The fat or bone marrow is harvested from the patient, and immediately processed for injection into the target area. Since the material comes directly from the patient, the risks are exceptionally low.

With regards to the amniotic derived injections, the fluid is obtained from consenting donors and processed at an FDA regulated lab. The treatment does not involve any fetal tissue, and contains a high concentration of stem cells, growth factors and anti-inflammatory factors.

The additional treatment offered is platelet rich plasma therapy, known as PRP therapy for short. PRP therapy involves a simple blood draw from the patient, which is then centrifuged and spun down for 15 minutes to obtain a solution rich in platelets and growth factors.

The PRP is then injected into the target area, where published studies have shown impressive results for arthritis and soft tissue injury such as rotator cuff tendonitis, tennis elbow, Achilles tendonitis, ligament injury and more. The treatments have the potential to not only provide pain relief, but also regenerate the damaged tissue or cartilage.

Numerous athletes over the past few years have turned to regenerative medicine to obtain pain relief and get back into playing condition. This has included athletes such as Hines Ward, Tiger Woods, Kobe Bryant, Rafael Nadal and many more.

The Arizona Pain Stem Cell Institute treats everyone from athletes to college students to executives, manual laborers, senior citizens and more. Board Certified and Award Winning Phoenix pain management doctors offer the stem cell treatments along with other cutting edge pain relief options such as radiofrequency ablation and spinal cord stimulator implants.

Over 50 insurance plans are accepted, and Arizona Pain Specialists offers 5 locations for convenience. Call (602) 507-6550 for scheduling.

Visit link:
Phoenix Pain Management Doctors at Arizona Pain Stem Cell Institute Now Offering 4 Stem Cell Treatments for Arthritis

UTHealth Researchers Study Stem Cell Treatments for Children with CP

By Stem Cell Treatment

Contact Information

Available for logged-in reporters only

Newswise HOUSTON (Dec. 10, 2013) A first-of-its-kind clinical trial studying two forms of stem cell treatments for children with cerebral palsy (CP) has begun at The University of Texas Health Science Center at Houston (UTHealth) Medical School.

The double-blinded, placebo-controlled studys purpose includes comparing the safety and effectiveness of banked cord blood to bone marrow stem cells. It is led by Charles S. Cox, Jr., M.D., the Childrens Fund, Inc. Distinguished Professor of Pediatric Surgery at the UTHealth Medical School and director of the Pediatric Trauma Program at Childrens Memorial Hermann Hospital. Co-principal investigator is Sean I. Savitz, M.D., professor and the Frank M. Yatsu, M.D., Chair in Neurology in the UTHealth Department of Neurology.

The study builds on Cox extensive research studying stem cell therapy for children and adults who have been admitted to Childrens Memorial Hermann and Memorial Hermann-Texas Medical Center after suffering a traumatic brain injury (TBI). Prior research, published in the March 2010 issue of Neurosurgery, showed that stem cells derived from a patients own bone marrow were safely used in pediatric patients with TBI. Cox is also studying cord blood stem cell treatment for TBI in a separate clinical trial.

A total of 30 children between the ages of 2 and 10 who have CP will be enrolled: 15 who have their own cord blood banked at Cord Blood Registry (CBR) and 15 without banked cord blood. Five in each group will be randomized to a placebo control group. Families must be able to travel to Houston for the treatment and follow-up visits at six, 12 and 24 months.

Parents will not be told if their child received stem cells or a placebo until the 12-month follow-up exam. At that time, parents whose children received the placebo may elect to have their child receive the stem cell treatment through bone marrow harvest or cord blood banked with CBR.

Collaborators for the study include CBR, Lets Cure CP, TIRR Foundation and Childrens Memorial Hermann Hospital. The study has been approved by the U.S. Food and Drug Administration.

Cerebral palsy is a group of disorders that affects the ability to move and maintain balance and posture, according to the Centers for Disease Control. It is caused by abnormal brain development or damage to the developing brain, which affects a persons control over muscles. Treatment includes medications, braces and physical, occupational and speech therapy.

For a list of inclusion and exclusion criteria for the trial, go to http://www.clinicaltrials.gov. For more information, call the toll-free number, 855-566-6273.

See the original post:
UTHealth Researchers Study Stem Cell Treatments for Children with CP

FAQs [Stem Cell Information]

By Stem Cell Doctors

Basic Questions

What are stem cells? Stem cells are cells that have the potential to develop into some or many different cell types in the body, depending on whether they are multipotent or pluripotent. Serving as a sort of repair system, they can theoretically divide without limit to replenish other cells for as long as the person or animal is still alive. When a stem cell divides, each "daughter" cell has the potential to either remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

For a discussion of the different kinds of stem cells, such as embryonic stem cells, adult stem cells, or induced pluripotent stem cells, see Stem Cell Basics.

What classes of stem cells are there? Stem cells may be pluripotent or multipotent.

Where do stem cells come from? There are several sources of stem cells. Pluripotent stem cells can be isolated from human embryos that are a few days old. Cells from these embryos can be used to create pluripotent stem cell "lines" cell cultures that can be grown indefinitely in the laboratory. Pluripotent stem cell lines have also been developed from fetal tissue (older than 8 weeks of development).

In late 2007, scientists identified conditions that would allow some specialized adult human cells to be reprogrammed genetically to assume a stem cell-like state. These stem cells are called induced pluripotent stem cells (iPSCs). IPSCs are adult cells that have been genetically reprogrammed to an embryonic stem celllike state by being forced to express genes and factors important for maintaining the defining properties of embryonic stem cells. Although these cells meet the defining criteria for pluripotent stem cells, it is not known if iPSCs and embryonic stem cells differ in clinically significant ways. Mouse iPSCs were first reported in 2006, and human iPSCs were first reported in late 2007. Mouse iPSCs demonstrate important characteristics of pluripotent stem cells, including expressing stem cell markers, forming tumors containing cells from all three germ layers, and being able to contribute to many different tissues when injected into mouse embryos at a very early stage in development. Human iPSCs also express stem cell markers and are capable of generating cells characteristic of all three germ layers.

Although additional research is needed, iPSCs are already useful tools for drug development and modeling of diseases, and scientists hope to use them in transplantation medicine. Viruses are currently used to introduce the reprogramming factors into adult cells, and this process must be carefully controlled and tested before the technique can lead to useful treatments for humans. In animal studies, the virus used to introduce the stem cell factors sometimes causes cancers. Researchers are currently investigating non-viral delivery strategies.

Non-embryonic (including adult and umbilical cord blood) stem cells have been identified in many organs and tissues. Typically there is a very small number of multipotent stem cells in each tissue, and these cells have a limited capacity for proliferation, thus making it difficult to generate large quantities of these cells in the laboratory. Stem cells are thought to reside in a specific area of each tissue (called a "stem cell niche") where they may remain quiescent (non-dividing) for many years until they are activated by a normal need for more cells, or by disease or tissue injury. These cells are also called somatic stem cells.

Why do scientists want to use stem cell lines? Once a stem cell line is established from a cell in the body, it is essentially immortal, no matter how it was derived. That is, the researcher using the line will not have to go through the rigorous procedure necessary to isolate stem cells again. Once established, a cell line can be grown in the laboratory indefinitely and cells may be frozen for storage or distribution to other researchers.

Stem cell lines grown in the lab provide scientists with the opportunity to "engineer" them for use in transplantation or treatment of diseases. For example, before scientists can use any type of tissue, organ, or cell for transplantation, they must overcome attempts by a patient's immune system to reject the transplant. In the future, scientists may be able to modify human stem cell lines in the laboratory by using gene therapy or other techniques to overcome this immune rejection. Scientists might also be able to replace damaged genes or add new genes to stem cells in order to give them characteristics that can ultimately treat diseases.

Read this article:
FAQs [Stem Cell Information]

How to Locate Stem Cell Clinical Trials | eHow

By Stem Cell Clinic

healthsection Health Topics A-Z Healthy Living Featured Conditions eHow Now eHow Health Conditions & Treatments Medical Conditions How to Locate Stem Cell Clinical Trials

Michele Starkey

Michele Starkey is a graduate of the Christian Writers Guild. Her stories have been published by Adams Media, F&W Publications and Thomas Nelson Publishers. After living the world over, she is currently residing in the Hudson Valley of New York and is a reporter for the hometown newspaper.

View my portfolio

Stem cells are "the building blocks of life that construct blood vessels, the nervous system, organs, and everything else that makes us human," according to the John Hopkins Medical Center (See Reference 1). The U.S. National Institutes of Health and other federal agencies and private industries such as pharmaceutical corporations sponsor a website to assist you in locating clinical trials both within the United States and abroad. (See Reference 2) Participation in stem cell clinical trials requires meeting the criteria outlined in each trial and signing an informed consent form.

Visit clinicaltrials.gov, a service provided by the National Institutes of Health in collaboration with other federal agencies, pharmaceutical industries and other private industries. Enter "stem cell" in the search box and receive a list of all actively recruiting stem cell clinical trials.

Sort the list. A link on the website allows you to view actively recruiting stem cell trials, completed trials and non-active trials.

Select the stem cell clinical trial that interests you. Read the eligibility requirements to ensure that you meet criteria.

If you have reviewed the clinical trial purpose and still have additional questions, contact the responsible party to obtain more information. The contact and location information is listed at the bottom of every stem cell clinical trial page.

Understand the location of the stem cell trial. The database is multinational and trials can be anywhere in the world.

View original post here:
How to Locate Stem Cell Clinical Trials | eHow

How to Volunteer for Clinical Stem Cell Research | eHow

By Stem Cell Clinic

healthsection Health Topics A-Z Healthy Living Featured Conditions eHow Now eHow Health Conditions & Treatments Medical Conditions How to Volunteer for Clinical Stem Cell Research

Now that Pres. Obama has revoked the Bush administration's restrictions on federal funding of embryonic stem cell research, patients everywhere are wondering how they can participate in a stem cell research study at the clinical level. Unfortunately, except in one special exception (see the Tips section below) it's still too early to talk about clinical research using embryonic stem cells. Scientists are still experimenting with animals to make sure treatments are both safe and effective. As to the Obama action, the National Institutes of Health has to write guidelines for conducting ethical research using federal tax dollars. (That will take until the middle of summer.) Once those guidelines are in place, NIH will begin evaluating research proposals and awarding grant funding. So, the promise of embryonic stem cell research is still far from being fulfilled in a clinical setting.

But there is already a lot of clinical (i.e., human focused) research being done using adult (non-embryonic) stem cells. These clinical trials are being conducted in a variety of diseases and disorders. Here are some tips on how to find and volunteer for clinical stem cell research. (NOTE: Stem cell research involving blood diseases such as leukemia has been ongoing for decades.)

Learn all you can about stem cells and stem cell biology. There's an awful lot of misinformation floating around. It's important that you understand the basics: the difference between embryonic stem cells, adult stem cells, and induced pluripotent (iPS) cells. The NIH is a great place to start. See the Resources section below for a link to NIH Web pages that give you all the information you need.

Learn all you can about clinical studies approved by the U.S. Food and Drug Administration (FDA). Stay away from treatments and therapies (usually offered outside the United States) that have not undergone the FDA-monitored pre-clinical and clinical experimentation process. These unapproved stem cell treatments are probably scams: unproven scientifically, hugely expensive, mostly ineffective and possibly dangerous. See the Resources section below for a link to FDA Web pages that provide a thorough background briefing on the clinical research process.

Speaking of scams, before you are tempted to apply for stem cell treatments offered in clinics outside the United States, educate yourself on the dangers of expensive, unproven stem cell therapies. The Resources section includes a link to the Web site of the International Society for Stem Cell Research. The organization offers a free 8-page handbook downloadable in PDF for patients tempted to go overseas for stem cell treatments. It includes a long list of questions to ask the treatment provider before you spend a nickel.

Once you've educated yourself about stem cells, clinical trials, and stem cell scams, you can easily locate clinical trials approved by the FDA that are recruiting patient volunteers. The FDA database is simple to search using key words (e.g., "stem cell AND heart attack"). I did a search recently on "Parkinson's AND stem cell" and found one clinical trial sponsored by two NIH institutes. The study was launched in 2002 and is still recruiting patients. The Resources section has the link to the search engine at ClinicalTrials.gov.

Once you've found a clinical study that you're interested in, read the eligibility requirements. These will tell who will be accepted and who will be rejected and why. If you meet the basic requirements, find the contact information. Then call or send an e-mail to ask for more information.

Lastly, consult your physician before applying for a clinical study. He or she may know something about your physical condition that would prevent you from participating in a study. It is important for clinical researchers to know everything about your physical history before accepting you.

You don't need a Ph.D. in biology to volunteer for a stem cell-based clinical study. But you really do need to bone up on the basics. Follow every step above and you'll be armed with enough information to ask the right questions and be accepted in the right study.

See the original post:
How to Volunteer for Clinical Stem Cell Research | eHow

The 2012 Nobel Prize in Physiology or Medicine – Press Release

By Uncategorized

Press Release

2012-10-08

The Nobel Assembly at Karolinska Institutet has today decided to award

The Nobel Prize in Physiology or Medicine 2012

jointly to

John B. Gurdon and Shinya Yamanaka

for the discovery that mature cells can be reprogrammed to become pluripotent

The Nobel Prize recognizes two scientists who discovered that mature, specialised cells can be reprogrammed to become immature cells capable of developing into all tissues of the body. Their findings have revolutionised our understanding of how cells and organisms develop.

John B. Gurdon discovered in 1962 that the specialisation of cells is reversible. In a classic experiment, he replaced the immature cell nucleus in an egg cell of a frog with the nucleus from a mature intestinal cell. This modified egg cell developed into a normal tadpole. The DNA of the mature cell still had all the information needed to develop all cells in the frog.

Shinya Yamanaka discovered more than 40 years later, in 2006, how intact mature cells in mice could be reprogrammed to become immature stem cells. Surprisingly, by introducing only a few genes, he could reprogram mature cells to become pluripotent stem cells, i.e. immature cells that are able to develop into all types of cells in the body.

Read the rest here:
The 2012 Nobel Prize in Physiology or Medicine - Press Release

MS-UK | Stem cells And MS Research

By Stem Cell Doctors

StemGenex continues to announce groundbreaking stem cell therapies for MS patients(03/12/13)

New targeted stem cell therapy looks to improve MS patients dealing with incontinence complications.

StemGenex, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today announced the newest therapy to assist patients diagnosed with Multiple Sclerosis.

According to the National MS Society, at least 80% of people with MS experience bladder dysfunction. StemGenex believes a new therapy delivering adipose derived mesenchymal cells directly to the bladder may reduce the inflammation that is causing the patients incontinence.

Direct bladder targeting is the latest in a series of targeted therapies StemGenex plans to announce in the next few months for patients dealing with degenerative diseases such as Parkinsons, Alzheimers, COPD and of course Multiple Sclerosis. Earlier this month StemGenex announced a new intranasal stem cell therapy. The goal of this new technique is to encourage more stem cells to travel through the blood brain barrier to target the damage caused by MS.

Stem cell treatment studies are currently being offered by StemGenex to patients diagnosed with Multiple Sclerosis and other degenerative neurological diseases. StemGenex takes a unique approach of compassion and empowerment while providing access to the latest stem cell therapies for degenerative neurological diseases including Parkinsons and Alzheimers disease, stroke recovery and others. Rita Alexander, founder of StemGenex and the companys first stem cell patient, insists that all patients be treated like they are one of our loved ones. "Hope, compassion, and the relentless pursuit for an end to these diseases are our primary focus."

Source: Copyright 1997-2013, Vocus PRW Holdings, LLC. Vocus, PRWeb (03/12/13)

A team of Ottawa doctors is preparing to publish a full report on its breakthrough multiple sclerosis treatment study that has so far eliminated the disease in those treated.

The experimental study began about 13 years ago as a last resort for patients who fail to improve on drug therapy and who suffer severe symptoms of MS. Snippets of the results have been published here and there, said, neurologist Dr. Mark Freedman, one of the leads of the program at The Ottawa Hospital, but its never been published in its entirety.

No specific date has been set for its release, but the teams findings are far from secret. With MS not returning in any of the 24 participants, patient success stories appear in news media across the country. Since the original studys completion, about another dozen patients have been treated with all of them showing the same results.

Go here to see the original:
MS-UK | Stem cells And MS Research

Stem-Cell Therapy and Repair after Heart Attack and Heart Failure

By Stem Cell Clinic

Stem Cell Therapy: Helping the Body Heal Itself

Stem cells are natures own transformers. When the body is injured, stem cells travel the scene of the accident. Some come from the bone marrow, a modest number of others, from the heart itself. Additionally, theyre not all the same. There, they may help heal damaged tissue. They do this by secreting local hormones to rescue damaged heart cells and occasionally turning into heart muscle cells themselves. Stem cells do a fairly good job. But they could do better for some reason, the heart stops signaling for heart cells after only a week or so after the damage has occurred, leaving the repair job mostly undone. The partially repaired tissue becomes a burden to the heart, forcing it to work harder and less efficiently, leading to heart failure.

Initial research used a patients own stem cells, derived from the bone marrow, mainly because they were readily available and had worked in animal studies. Careful study revealed only a very modest benefit, so researchers have moved on to evaluate more promising approaches, including:

No matter what you may read, stem cell therapy for damaged hearts has yet to be proven fully safe and beneficial. It is important to know that many patients are not receiving the most current and optimal therapies available for their heart failure. If you have heart failure, and wondering about treatment options, an evaluation or a second opinion at a Center of Excellence can be worthwhile.

Randomized clinical trials evaluating these different approaches typically allow enrollment of only a few patients from each hospital, and hence what may be available at the Cleveland Clinic varies from time to time. To inquire about current trials, please call 866-289-6911 and speak to our Resource Nurses.

Cleveland Clinic is a large referral center for advanced heart disease and heart failure we offer a wide range of therapies including medications, devices and surgery. Patients will be evaluated for the treatments that best address their condition. Whether patients meet the criteria for stem cell therapy or not, they will be offered the most advanced array of treatment options.

Reviewed: 04/13

See the original post here:
Stem-Cell Therapy and Repair after Heart Attack and Heart Failure

Perelman School of Medicine at the University of Pennsylvania

By Uncategorized

Activating Pathway Could Restart Hair Growth in Dormant Hair Follicles, Penn Study Suggests

5 Dec 2013A pathway known for its role in regulating adult stem cells has been shown to be important for hair follicle proliferation, but contrary to previous studies, is not required within hair follicle stem cells for their survival, according to researchers with the Perelman School of Medicine at the... Read more

4 Dec 2013Brendan G. Carr, MD, MA, MS, assistant professor of Emergency Medicine and Epidemiology at the Perelman School of Medicine at the University of Pennslyvania, has been named as the director of the Emergency Care Coordination Center (ECCC). Read more

3 Dec 2013Compared to traditional mammography, 3D mammographyknown as digital breast tomosynthesisfound 22 percent more breast cancers and led to fewer call backs in a large screening study at the Hospital of the University of Pennsylvania (HUP), researchers reported today at the annual meeting of th... Read more

2 Dec 2013A new brain connectivity study from Penn Medicine published today in the Proceedings of National Academy of Sciences found striking differences in the neural wiring of men and women thats lending credence to some commonly-held beliefs about their behavior. Read more

29 Nov 2013A new, first-of-its-kind study by researchers at the Perelman School of Medicine at the University of Pennsylvania seeks to learn whether men with prostate cancer who are undergoing radiation therapy can benefit from yoga. The study, led by Neha Vapiwala, MD, assistant professor of Radiation... Read more

Continue reading here:
Perelman School of Medicine at the University of Pennsylvania

Cell – Official Site

By Uncategorized

Cell Press celebrates the achievements of James E. Rothman, Randy W. Schekman, and Neuron Editorial Board member Thomas C. Sdhof, recipients of the 2013 Nobel Prize in Physiology or Medicine and congratulates Structure Editorial Board member Martin Karplus, Biophysical Journal Editorial Board member Michael Levitt, and Arieh Warshel , the recipients of the 2013 Nobel Prize in Chemistry. Read the award winners' research published in Cell Press journals FREE.

KI @ MITImage Awards II: Scientific data comes in many flavors and types, but a special place is reserved for images. Micrographs, MRI scans, and other biomedical images serve as windows through which experts and nonscientists alike can glimpse otherwise invisible biological worlds. The MIT Koch Institute Image Awards were established to recognize and publicly display these extraordinary visuals. This show highlights the 2013 Koch Image Award Winners.

View more slideshows.

Cell Picture Show thanks our sponsor.

Please join us for a FREE webinar and hear Angela Stathopoulos and Roberto Weigert discuss the processes that shape the developing embryo and form biological structures as well as the latest imaging techniques in this field.

Please join us for a FREE webinar and hear Dr. Carlo Croce and Dr. Joshua Mendell share their latest insights into the role of miRNAs in cancer.

Click here to view Reviews, Perspectives, and Forum articles on the progress and prospects for therapeutic application of induced pluripotent stem cells.

More here:
Cell - Official Site

→←